BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36853660)

  • 1. CRISPR-Cas9-mediated insertion of a short artificial intron for the generation of conditional alleles in mice.
    Cassidy A; Pelletier S
    STAR Protoc; 2023 Mar; 4(1):102116. PubMed ID: 36853660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step generation of a conditional allele in mice using a short artificial intron.
    Cassidy AM; Thomas DB; Kuliyev E; Chen H; Pelletier S
    Heliyon; 2022 Dec; 8(12):e12630. PubMed ID: 36619446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step CRISPR-Cas9 protocol for the generation of plug & play conditional knockouts in
    Yu JJS; Vincent JP; McGough IJ
    STAR Protoc; 2021 Jun; 2(2):100560. PubMed ID: 34095868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small cassette enables conditional gene inactivation by CRISPR/Cas9.
    Guzzardo PM; Rashkova C; Dos Santos RL; Tehrani R; Collin P; Bürckstümmer T
    Sci Rep; 2017 Dec; 7(1):16770. PubMed ID: 29196747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in
    Chilian M; Vargas Parra K; Sandoval A; Ramirez J; Yoon WH
    STAR Protoc; 2022 Sep; 3(3):101465. PubMed ID: 35719725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of epitope tag knock-in mice with CRISPR-Cas9 to study the function of endogenous proteins.
    Zhang Z
    STAR Protoc; 2023 Sep; 4(3):102518. PubMed ID: 37585297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
    Wang X; Xu BL; Chen XW
    STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting endogenous proteins for spatial and temporal knockdown using auxin-inducible degron in Caenorhabditis elegans.
    Kurashina M; Mizumoto K
    STAR Protoc; 2023 Mar; 4(1):102028. PubMed ID: 36640369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
    Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
    STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
    Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
    STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
    Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
    STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCON-a Short Conditional intrON for conditional knockout with one-step zygote injection.
    Wu SS; Lee H; Szép-Bakonyi R; Colozza G; Boese A; Gert KR; Hallay N; Lee JH; Kim J; Zhu Y; Linssen MM; Pilat-Carotta S; Hohenstein P; Theussl HC; Pauli A; Koo BK
    Exp Mol Med; 2022 Dec; 54(12):2188-2199. PubMed ID: 36494589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol to efficiently induce CRISPR-Kill-mediated cell ablation in Arabidopsis thaliana.
    Gehrke F; Wolf S; Puchta H
    STAR Protoc; 2024 Jun; 5(2):103072. PubMed ID: 38768032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.